Chair to Seek Re-Election; Director Nominations

Pacific Edge today advises Chairman Chris Gallaher has accepted an invitation by the company’s Directors to seek re-election to the Board at the company’s Annual Shareholders’ Meeting (ASM) to be held on Wednesday 6 August 2025 starting at 1.00pm in Auckland.

Pacific Edge’s Directors extended the invitation because they believe shareholders’ best interests are served with the continuity and stability of Mr Gallaher’s leadership while the company continues to navigate the loss of Medicare coverage for Cxbladder products.

In September 2024 Mr Gallaher signaled his intention to step down this year (2025). He is also due to retire from the Board by rotation at the ASM in accordance with NZX Listing Rule 2.7.1. but will now be standing for re-election. Independent Directors Sarah Park and Tony Barclay, who are also due to retire by rotation in accordance with NZX Listing Rule 2.7.1, have indicated they will also stand for re-election.

Mr Gallaher said: “The inclusion of Cxbladder Triage in the American Urological Association’s new microhematuria guideline has allowed Pacific Edge to view the Local Coverage Determination that ended Medicare coverage of our tests through a different lens. As we move through the process to seek re-coverage, I am happy to continue as Chairman to ensure we have Board stability and continuity.”

DIRECTOR NOMINATIONS

For the purposes of Listing Rule 2.3.2, Pacific Edge meanwhile advises that the closing date for Director nominations is Tuesday 1 July 2025.

All nominations must be received by 4.00pm on the closing date. Nominations may only be made by a shareholder entitled to attend and vote at the Annual Shareholder Meeting and must be accompanied by a consent in writing by the nominated person.

Nominations should be either emailed to investors@pacificedge.co.nz or addressed to:

Director Nominations
Pacific Edge Limited
PO Box 56
Dunedin 9016
New Zealand

Further details, including proxy voting forms and details of resolutions, will be provided in the Notice of Meeting, which will be sent to shareholders prior to the meeting.